l-Hypaphorine and d-hypaphorine: Specific antiacetylcholinesterase activity in rat brain tissue

Murilo K A Yonekawa,Bruna de B Penteado,Amanda Dal'Ongaro Rodrigues,Estela M G Lourenço,Euzébio G Barbosa,Silvia C das Neves,Rodrigo J de Oliveira,Maria R Marques,Denise B Silva,Dênis P de Lima,Adilson Beatriz,Jean P Oses,Jeandre A Dos S Jaques,Edson Dos A Dos Santos
DOI: https://doi.org/10.1016/j.bmcl.2021.128206
2021-09-01
Abstract:Acetylcholinesterase (AChEis) inhibitors are used to treat neurodegenerative diseases like Alzheimer's disease (AD). l-Hypaphorine (l-HYP) is a natural indole alkaloid that has been shown to have effects on the central nervous system (CNS). The goal of this research was to synthesize l-HYP and d-HYP and test their anticholinesterasic properties in rat brain regions. l-HYP suppressed acetylcholinesterase (AChE) activity only in the cerebellum, whereas d-HYP inhibited AChE activity in all CNS regions studied. No cytotoxic effect on normal human cells (HaCaT) was observed in the case of l-HYP and d-HYP although an increase in cell proliferation. Molecular modeling studies revealed that d-HYP and l-HYP have significant differences in their binding mode positions and interact stereospecifically with AChE's amino acid residues.
What problem does this paper attempt to address?